Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination.

Literature DB >> 10456954

Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination.

K R Lottenbach¹, C M Mink, S J Barenkamp, E L Anderson, S M Homan, D C Powers.

Abstract

Immunoglobulin G (IgG) subclass antibody responses to pneumococcal vaccines were determined for human subjects in four age groups. The ratios of IgG1/IgG2 antibody concentrations declined with advancing age for all five of the serotypes tested. Protein-conjugate vaccines elicited enhanced IgG antibody responses over plain polysaccharide vaccines in infants but not in adult groups.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1999 PMID： 10456954 PMCID： PMC96832

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

17 in total

1. Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of the 2nd IUIS/WHO collaborative study.

Authors: R Jefferis; C B Reimer; F Skvaril; G G de Lange; D M Goodall; T L Bentley; D J Phillips; A Vlug; S Harada; J Radl
Journal: Immunol Lett Date: 1992-02 Impact factor: 3.685

Review 2. Polysaccharide-protein conjugates: a new generation of vaccines.

Authors: J B Robbins; R Schneerson
Journal: J Infect Dis Date: 1990-05 Impact factor: 5.226

3. Use of monoclonal antibodies to quantify subclasses of human IgG. I. Development of two-site immunoenzymometric assays for total IgG subclass determinations.

Authors: R Hussain; R W Poindexter; R Wistar; C B Reimer
Journal: J Immunol Methods Date: 1986-10-23 Impact factor: 2.303

4. Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.

Authors: M Anttila; J Eskola; H Ahman; H Käyhty
Journal: Vaccine Date: 1999-04-09 Impact factor: 3.641

5. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model.

Authors: E Reizenstein; H O Hallander; W C Blackwelder; I Kühn; M Ljungman; R Möllby
Journal: J Immunol Methods Date: 1995-06-28 Impact factor: 2.303

6. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S.

Authors: S A Quataert; C S Kirch; L J Wiedl; D C Phipps; S Strohmeyer; C O Cimino; J Skuse; D V Madore
Journal: Clin Diagn Lab Immunol Date: 1995-09

7. Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera.

Authors: M A French; G Harrison
Journal: Clin Exp Immunol Date: 1984-05 Impact factor: 4.330

8. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children.

Authors: A Freijd; L Hammarström; M A Persson; C I Smith
Journal: Clin Exp Immunol Date: 1984-05 Impact factor: 4.330

9. IgG subclasses of pneumococcal antibodies--effect of allotype G2m(n).

Authors: H Sarvas; N Rautonen; S Sipinen; O Mäkelä
Journal: Scand J Immunol Date: 1989-02 Impact factor: 3.487

10. IgG2 subclass restriction of antibody to pneumococcal polysaccharides.

Authors: D J Barrett; E M Ayoub
Journal: Clin Exp Immunol Date: 1986-01 Impact factor: 4.330

24 in total

Review 1. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

Authors: Catherine M Wernette; Carl E Frasch; Dace Madore; George Carlone; David Goldblatt; Brian Plikaytis; William Benjamin; Sally A Quataert; Steve Hildreth; Daniel J Sikkema; Helena Käyhty; Ingileif Jonsdottir; Moon H Nahm
Journal: Clin Diagn Lab Immunol Date: 2003-07

2. Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine.

Authors: Helen Findlow; Jo Southern; Lesley Mabey; Paul Balmer; Robert S Heyderman; Cressida Auckland; Rhonwen Morris; Elizabeth Miller; Ray Borrow
Journal: Clin Vaccine Immunol Date: 2006-04

3. A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice.

Authors: Ulrike K Buchwald; Andrew Lees; Michael Steinitz; Liise-Anne Pirofski
Journal: Infect Immun Date: 2005-01 Impact factor: 3.441

4. Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides.

Authors: Richarda M de Voer; Fiona R M van der Klis; Carla W A M Engels; Ger T Rijkers; Elisabeth A Sanders; Guy A M Berbers
Journal: Clin Vaccine Immunol Date: 2008-06-11

Review 5. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors: S Sethi; T F Murphy
Journal: Clin Microbiol Rev Date: 2001-04 Impact factor: 26.132

6. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.

Authors: C L Vermont; H H van Dijken; C J P van Limpt; R de Groot; L van Alphen; G P J M van Den Dobbelsteen
Journal: Infect Immun Date: 2002-02 Impact factor: 3.441

7. Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.

Authors: Elizabeth A Clutterbuck; Sarah Oh; Mainga Hamaluba; Sharon Westcar; Peter C L Beverley; Andrew J Pollard
Journal: Clin Vaccine Immunol Date: 2007-11-21

8. IgG subclass response to Helicobacter pylori and CagA antigens in children.

Authors: K Dzierzanowska-Fangrat; M Raeiszadeh; D Dzierzanowska; M Gladkowska-Dura; D Celinska-Cedro; J E Crabtree
Journal: Clin Exp Immunol Date: 2003-12 Impact factor: 4.330

Review 9. Pneumococcal vaccination and revaccination of older adults.

Authors: Andrew S Artz; William B Ershler; Dan L Longo
Journal: Clin Microbiol Rev Date: 2003-04 Impact factor: 26.132

10. Neutrophils Are Required During Immunization With the Pneumococcal Conjugate Vaccine for Protective Antibody Responses and Host Defense Against Infection.

Authors: Essi Y I Tchalla; Manmeet Bhalla; Elizabeth A Wohlfert; Elsa N Bou Ghanem
Journal: J Infect Dis Date: 2020-09-14 Impact factor: 5.226